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INTRODUCTION 
 
Skeletal muscle dysfunction associated with 
ischemia/reperfusion (I/R) injury is in part attributed to 
increased oxidative stress and oxidative protein 
modification [1-3] This oxidative stress is associated 
with mitochondrial ROS production, the inflammatory 
response resulting from the action of cytokines and the 
infiltration of inflammatory cells which increase in I/R 
during reoxygenation following reperfusion [1, 4]. 
 
Ischemia is a common problem in clinical practice. It is 
estimated that by 2030 there will be 1-2 million 
vascular surgery cases per year in the United States [5], 
and I/R is a major component of these cases [6]. In 
addition, utilization of flaps during reconstructive 
surgery,  tourniquets  during  orthopedic  surgery,  com- 
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partment syndrome following surgery or trauma, sepsis, 
critical limb ischemia, and thromboembolic events can 
all lead to I/R injury [2, 7, 8]. Many of these clinical 
situations are more common in elderly patients, who 
may be experiencing age-related muscle dysfunction. 
As oxidative stress and protein modification play a role 
in aging and I/R injury, it might be expected that I/R 
injury would have a more severe effect on muscle 
function in the elderly. Recent research in a rodent 
model of I/R are consistent with this idea [2]; however, 
the degree to which oxidative modification may play a 
role in this cumulative effect and the mechanisms by 
which oxidative protein modification may lead to 
muscle dysfunction are not well understood.  
 
The metabolic phenotype of muscle fibers directly 
influences their susceptibility to oxidative stress. During 
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Abstract: Aging and skeletal muscle ischemia/reperfusion (I/R) injury leads to decreased contractile force generation that
increases  severely  with  age.  Our  studies  show  that  glyceraldehyde‐3‐phosphate  dehydrogenase  (GAPDH)  protein
expression is significantly decreased at 3 and 5 days reperfusion in the young mouse muscle and at 1, 3, 5, and 7 days in the
aged muscle. Using PCR, we have shown that GAPDH mRNA levels in young and old muscle increase at 5 days reperfusion
compared to control, suggesting that the protein deficit is not transcriptional. Furthermore, while total tyrosine nitration
did not increase in the young muscle, GAPDH nitration increased significantly at 1 and 3 days reperfusion. In contrast, total
tyrosine nitration  in  aged muscle  increased significantly  at  1, 3,  and  5  days  of  reperfusion,  with  increases  in  GAPDH
nitration  at  the  same  time  points.  We  conclude  that  GAPDH  protein  levels  decrease  following  I/R,  that  this  is  not
transcriptionally mediated, that the aged muscle experiences greater oxidative stress, protein modification and GAPDH
degradation, possibly contributing to decreased muscle function. We propose that tyrosine nitration enhances GAPDH
degradation following I/R and that the persistent decrease of GAPDH in aged muscle is due to the prolonged increase in
oxidative modification in this age group.  
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and fiber size for glycolytic skeletal muscles [9, 10]. 
Oxidative stress appears to have a greater impact upon 
mitochondrial electron transport chain function in 
glycolytic skeletal muscles compared to oxidative 
muscles [11]. Furthermore, the degree of glycolytic 
phenotype in skeletal muscle correlates with 
susceptibility to cachexia as a result of chronic disease 
in humans and in models of cachexia both in mouse 
muscle in vivo or mouse cell lines [12]. It is suggested 
that this is the result of increased anti-oxidant defenses 
and inducible nitric oxide synthase. The increased 
susceptibility of primarily glycolytic muscle to 
oxidative stress is the rationale for studying glycolytic 
skeletal muscle in the present work, as this fiber type 
would likely be the most severely impacted by injury. 
Furthermore, we chose to study the effects of oxidative 
stress because of its central role in the regulation of the 
glycolytic pathway which is an important source of 
energy. 
 
Nitric oxide has been reported to increase in I/R injury 
although the timing and duration of the increase vary 
with experimental conditions [3, 13-15]. While at 
specific concentrations nitric oxide may be a protective 
factor in certain tissue stress signaling processes, excess 
nitric oxide can be detrimental [12, 16]. For example, 
interactions of nitric oxide with ROS can lead to several 
different types of post-translational modifications (for 
reviews, see [17-19]. Thus, when combined with 
superoxide, nitric oxide leads to the formation of 
damaging products [20], whether peroxynitrite [21] or 
one of peroxynitrite’s potential end products, tyrosine 
nitration [22]. While some nitrosative modifications 
such as cysteine nitrosylation have been shown 
convincingly to be involved in signaling mechanisms 
[23-25], tyrosine nitration is usually considered to be an 
indication of high oxidative and nitrative stress that 
results in protein damage. Nitrotyrosine adducts are 
formed  in vivo by two primary reaction pathways. 
These include (a) the reaction of nitric oxide with 
superoxide leading to peroxynitrite production and (b) 
the reaction of nitrite and hydrogen peroxide with 
various heme peroxidases. Both of these reactions lead 
to formation of a tyrosyl radical, followed by addition 
of nitrogen dioxide to yield 3-nitrotyrosine [26]. In I/R 
injury, both mechanisms of tyrosine nitration are likely 
to be elevated, due to the infiltration of immune cells, 
activation of iNOS, and increased ROS production [3].  
To examine the role of aging and oxidative stress in 
muscle dysfunction following I/R injury, we used a hind 
limb tourniquet model to induce I/R injury in young and 
old mice. GAPDH protein and mRNA levels were 
assessed to provide insight into the effects of I/R injury 
on glycolytic activity. Protein tyrosine nitration was 
evaluated, and in addition to GAPDH, several other 
nitrated proteins were identified via 2D gel 
electrophoresis and mass spectrometry. 
 
RESULTS 
 
The effect of I/R on GAPDH pool levels in 
plantaris/FHL from young and aged mice  
 
Glycolytic muscle mass decreases following I/R injury, 
particularly in muscle of old rats, suggesting a decrease 
in protein content [2]. Furthermore, the decrease in 
force production after I/R injury is greater for old 
muscle suggesting that decreased force production is 
related to decreased expression of glycolytic and 
contractile proteins [2]. Based on these observations we 
determined the protein pool levels of GAPDH for young 
and old mouse glycolytic skeletal muscle subjected to 
I/R injury (Figures 1, 2). Prior to normalization of the 
Western blot data, the comparison of GAPDH protein 
levels between young control and ischemic muscle 
showed no statistically significant difference after 2 
hours ischemia with no reperfusion (Figure 1A, 1B 
Group I), after 1 day reperfusion (Group II), or after 7 
days reperfusion (Figure 1A, 1B Group V). At the 3 and 
5 day time points (Groups II and IV) the GAPDH 
protein levels were significantly decreased in the I/R 
tissue, with an average decrease of 89.4% (p=.0004) at 
3 days and 71.4% (p=0.007) at 5 days (Figure 1B). 
 
Similar analyses of the GAPDH protein levels in old 
muscle showed a significant decrease after reperfusion 
at days 1 (Group I; 61.9%, p= 0.0005), 3 (Group II; 
83.1%, p=0.014), 5 (Group III; 83.3%, p= 0.007), and 7 
(Group IV; 73.8%, p= 0.013) of reperfusion (Figure 2A, 
2B). The no reperfusion time point was not available for 
the old animals. 
 
Although statistically significant differences in GAPDH 
pool level were seen at several time points in both age 
groups, a confounding variable in the data was the 
question of protein degradation in the ischemic muscle 
as related to the I/R injury. An examination of the post-
transfer gels after Coomassie staining revealed an 
increase in low molecular weight bands (< 16 kD) in the 
ischemic samples after reperfusion. Further, comparison 
of the total protein staining of the one-dimensional gel 
electrophoresis revealed that the average decrease of 
GAPDH over all days of reperfusion in the young was 
16.2% (p= 0.003 compared to young control).  
 
In the old muscle, there was a 16.6% decrease 
compared to old controls (p< 0.0001) as indicated by 
staining the I/R samples, after equalizing protein input 
prior to loading of the gels. Significantly, the samples 
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ischemia but no reperfusion showed no statistically 
significant differences in protein loading between 
control and ischemic muscle. In order to correct for 
differences in the amount of protein actually present in 
the gel, a normalization factor based on the Coomassie 
staining of the post-transfer gels was used (as described 
in Methods).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
After normalizing for background levels of protein 
degradation, the pool level of GAPDH in glycolytic 
skeletal muscle from young mice was still significantly 
decreased at 3 and 5 days of reperfusion (p=0.001 and 
0.005 respectively). There were no significant 
alterations at 2 hours of ischemia without reperfusion at 
day 1 or at day 7 of reperfusion. After normalization for 
protein degradation the GAPDH protein pool levels in 
skeletal muscle from the old mice were still 
significantly decreased at 1, 3, 5, and 7 days reperfusion 
(p=0.001, 0.015, 0.011, and 0.007, respectively). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total RNA from control and ischemic plantaris 
following 5 days of reperfusion 
 
We examined the possibility that altered GAPDH 
transcription may play a role in the decrease in GAPDH 
pool levels. Total RNA from plantaris muscle was 
isolated from young and old mice subjected to 2 hours 
of ischemia and 5 days of reperfusion. An equal 
percentage of total RNA from each sample was 
analyzed using a chip-based gel electrophoresis assay to 
determine the quality of isolated RNA. Surprisingly, the 
yield of total RNA from the ischemic samples was 
substantially higher compared to the contralateral 
Figure  1.  GAPDH  pool  levels  in  plantaris/FHL  lysate
from  young  mice.  Protein  (30  µg)  from  total  muscle  cell
lysates  of  plantaris/FHL  from  young  mice  (6‐7  months)
subjected to two hours of ischemia were separated by SDS‐
PAGE, transferred to PVDF membrane, and blotted with anti‐
GAPDH  antibody.  (A)  Group  I:  No  reperfusion,  showed  no
significant  difference.  Group  II:  One  day  reperfusion  shows
that GAPDH levels decreased, but not significantly. Groups III
and IV: Three and five days reperfusion, respectively, showed
a significant reduction in GAPDH immunoreactive pool levels
(p = 0.0004 and p = 0.007, respectively). Group V: Seven days
reperfusion showed no significant difference between control
and I/R muscle samples. (B) A bar graph showing the statistical
differences in GAPDH  pool  levels  in  response  to  2 hours  of
ischemia and 1‐7 days of reperfusion.  
Figure 2. GAPDH pool levels in plantaris/FHL lysate from 
old  mice.  Protein  (30  µg)  from  total  muscle  cell  lysates  of 
plantaris/FHL from old mice (24‐27 months) subjected to two 
hours of ischemia were separated by SDS‐PAGE, transferred to 
PVDF  membrane,  and  blotted  with  anti‐GAPDH  antibody.  (A) 
Groups  I,  one  day;  II,  3  days,  III,  5  days  and  IV,  7  days  of 
reperfusion  all  showed  statistically  significant  decreases  in 
GAPDH immunoreactive pool levels. (B) A bar graph showing the 
statistical  differences  in  GAPDH  pool  levels  in  response  to  2 
hours of ischemia and 1‐7 days of reperfusion.  
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indicate that the bulk of the increase in total RNA was 
from rRNA as measured by18s and 28s ribosomal 
subunits (Figure 3A and B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PCR analysis of GAPDH transcript levels from 
control and I/R plantaris  following 5 days of 
reperfusion  
 
To determine whether mRNA levels are affected, 
GAPDH-specific primers were used to perform PCR on 
an equal percent of the total cDNA (Figure 4). 
Significant differences were detected in the number of 
cycles to threshold (Ct) between young ischemic and 
young controls, with an average difference of 6.2 cycles 
(p=0.0009).  
 
The difference between the old controls and old 
ischemics was also significant (p=0.049), with an 
average difference of 5.4 cycles (Figure 4B). These data 
clearly show that there is a decrease in the GAPDH 
transcript levels in the I/R muscles. The difference in 
GAPDH transcript levels in response to I/R between the 
young and the old was not statistically significant. 
However, the data (threshold levels) suggest that the 
average level of GAPDH mRNA in the young muscle is 
approximately twice the level in the old (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Analysis of total RNA from control and ischemic
plantaris  muscle  following  5  days  of  reper‐fusion.  An
equal percentage of total RNA from (A) six separate samples of
young (6‐7 months) and (B) 3 separate samples of old (24‐27
months)  plantaris  muscle  was  analyzed  by  capillary  gel
electrophoresis. The initial peak is a marker (M) included for
calibration. Control and I/R samples are the contralateral and
ischemic  muscle  from  the  same  animal.  Samples  are  paired
from left to right, beginning with control. C = control; T = I/R;
small  ribosomal  subunit  (18s)  and  large  ribosomal  subunit
(28s). 
Figure 4. PCR analysis of GAPDH transcript levels from 
control  and  I/R  plantaris  muscle  following  5  days  of 
reperfusion. PCR with GAPDH specific probes was performed 
using an equal percentage of  total cDNA (reverse transcribed 
from mRNA using igo(d)T primers) isolated from each sample 
of (A) young (6‐7 months) and (B) old (24‐27 months) plantaris 
muscle. Control = black; I/R = gray; T = Threshold (arrow shows 
the threshold). 
   
www.impactaging.com                  1006                                      AGING, October 2  011, Vol.3   No.10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Detection of nitrotyrosine modified proteins  
 
Previous studies have shown functional impairment of 
glycolytic skeletal muscle following I/R injury [2]. 
Oxidative modification of proteins critical for muscle 
function is a possible mechanism explaining the decline 
in muscle force production. As levels of reactants 
necessary to form nitrotyrosine are known to increase 
during the reperfusion stage of I/R injury, we tested the 
hypothesis that protein tyrosine nitration would increase 
following reperfusion. Relative levels of protein 
tyrosine nitration were assayed in skeletal muscle 
extract from young (Figure 5) and old (Figure 6) mice 
following I/R by one-dimensional gel electrophoresis 
and Western blotting with antibody specific for 
nitrotyrosine. The corresponding contralateral muscles 
were used as a control for the basal level of nitration 
(Figures 5, 6). Following normalization for back-ground 
protein degradation, there were no statistically significant 
differences in total nitrotyrosine for the young, although 
nitration was increased at every time point following 
reperfusion (Figure 5; range 22% to 67% increase).  
 
In contrast to the young, an analysis of total tyrosine 
nitration in whole cell lysates of old skeletal muscle 
following I/R revealed statistically significant increases 
at the 1, 3, and 5 day time points (Figure 6; p = 0.008, 
0.048 and 0.03, respectively). Total nitration was 
increased at all time points, but the increase was not 
significant at the 7 day time point (Figure 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Two-dimensional gel electrophoresis  
Figure 5. Western blot analysis of total tyrosine nitration
of plantaris/ FHL lysate from young mice following I/R.
(A) Tyrosine nitration of whole cell lysate of glycolytic skeletal
muscle from young (6‐7 months) mice with 2 hours ischemia and
variable lengths of reperfusion was examined by Western blot. C
= contralateral control; Is = I/R; Group I = no reperfusion; Group
II = 1 day reperfusion; Group III = 3 days reperfusion; Group IV =
5  days  reperfusion,  and  Group  V  =  7  days  reperfusion.  (B)
Densitometric  analysis  shows  no  statistically  significant
differences in levels of overall nitration. 
Figure  6.  Western  blot  analysis  of  total  tyrosine  nitration  of
plantaris/FHL lysate from old mice following I/R. (A) Tyrosine nitration
of whole cell lysate of glycolytic skeletal muscle from old mice (24‐27 months)
with 2 hours ischemia and variable lengths of reperfusion was examined by
Western blot. C = contralateral control; Is = I/R; Group I = 1 day reperfusion;
Group II = 3 days reperfusion; Group III = 5 days reperfusion, and Group IV = 7
days  reperfusion.  (B)  Densitometric  analysis  shows  statistically  significant
differences were observed at 1, 3, and 5 days of reperfusion. 
   
www.impactaging.com                  1007                                      AGING, October 2  011, Vol.3   No.10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
While evaluating overall levels of an oxidative 
modification is useful as an indication of oxidative 
stress in a tissue, knowing which specific proteins are 
targeted by posttranslational modifications can further 
provide an understanding of the consequences of the 
modifications. Therefore, experiments were undertaken 
to identify those proteins which were targets of tyrosine 
nitration in I/R injury. Two-dimensional gel 
electrophoresis was used to resolve lysate proteins from 
young (6 months) and old (24-27 months) muscles 
previously assayed by one dimensional gel 
electrophoresis and western blot (Figure 7). The five 
day reperfusion time points were selected for analysis. 
Anti-nitrotyrosine western blotting was used to select 
spots from a second gel of the same sample (focused 
concurrently with the gel used for Western blotting) for 
identification via MALDI-TOF mass spectrometry. A 
list of identified proteins is included in Table 1. Protein 
scores greater than 53 were considered to be significant.  
Of the proteins identified by mass spectrometry in the 
old muscle following I/R, approximately 30% were also 
identified in the young following I/R. It was noted that 
several enzymes in the glycolytic pathway were 
identified as nitrated, based on Western blot selection 
for MALDI-TOF. Three of these enzymes, GAPDH, 
triose phosphate isomerase, and fructose bis-phosphate 
aldolase A, were identified from both young and old. 
Since glycolysis is necessary to maintain adequate ATP 
levels during I/R injury, any effect on the activities of 
these enzymes might have a significant effect on ATP 
levels and consequently on energy availability. 
 
Identification of nitrated GAPDH in young and old 
muscle  
 
After identifying the nitrated proteins from I/R samples, 
we compared the 37 kD band corresponding to the 
molecular weight of GAPDH across the time course. 
We focused on GAPDH due to its importance in 
glycolysis, reports of altered GAPDH function with 
posttranslational modification i.e., nitrosylation [23], 
and a recent report that overexpression of GAPDH can 
rescue cells in culture from caspase-independent cell 
death [27]. These reports suggest that GAPDH has 
multiple functions and may integrate different cellular 
activities with the metabolic state of the cell [28].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure7. Nitrotyrosine western blot analysis of 2D gel
electrophoresis of young and old plantaris/FHL lysate
following 5 days of reperfusion. Plantaris/FHL lysates (180
µg) from (A) young (6‐7 months) or (B) old (24‐27 months) I/R
tissues  were  separated  by  2D  gel  electrophoresis.
Nitrotyrosine immunoblotting was used to select nitrotyrosine
modified proteins from a duplicate gel for mass spectrometry
and identification.  
Figure 8. Tyrosine nitration of GAPDH in plantaris/FHL 
lysate from young mice. (A) Tyrosine nitration was assessed 
by  Western  blot  of  one  dimensional  gel  electrophoresis.  (B) 
Densitometric  analysis  shows  nitration  was  significantly 
increased for GAPDH at 1 and 3 days of reperfusion, with the 
greatest  increase  at  3  days  reperfusion.  C  =  contralateral 
control; Is = I/R; Group I = no reperfusion; II = 1 day reperfusion; 
Group III = 3 days reperfusion; Group IV = 5 days reperfusion, 
and Group V = 7 days reperfusion. * = p < 0.05.  
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GAPDH protein pool levels as measured by Western 
blotting, it was found that the nitration of GAPDH in 
the young was significantly increased at the one and 
three day time points (Figure 8; p= 0.001 and 0.043 
respectively). The highest level of nitration in the 
samples from young mice occurs at the 3 day time 
point.  
 
After normalization to GAPDH pool level, the nitration 
of the 37 kD band in the samples from old mice was 
significantly increased at 1, 3, and 5 days reperfusion 
(Figure 9; p = 0.019, 0.048, and 0.011, respectively). In 
contrast to the young, the highest levels of nitration 
measured were at the 5 and 7 day time points. However, 
the increase in nitration was not statistically significant 
at 7 days due to the variability within the I/R group 
(Figure 9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comparing the percent increase in nitration (control to 
I/R) of the 37 kD band, a significant difference (p= 
0.02) was noted between the young and old skeletal 
muscle at the 5 day time point corresponding to the 
peak of GAPDH nitration in the old. The level of 
nitration in the young had decreased by the 5
th day with 
the peak of the increase in nitration appearing at the 3
rd 
day of reperfusion. In summary, the greatest difference 
between control and I/R in the young occurs at 3 days 
of reperfusion, while the greatest difference in the old 
occurs at 5 days of reperfusion. 
 
DISCUSSION 
 
We have presented evidence that following I/R, 
GAPDH protein levels decrease in both young and old 
mouse skeletal muscle while levels of nitrated GAPDH 
increase. Our observations are consistent with the 
reports that oxidative protein modifications increase 
protein degradation [29, 30] and suggest a model of 
protein homeostasis in which increased oxidative 
modification and subsequent degradation of proteins 
leads to decreases in protein pool levels.  
 
Our experiments show evidence of increased proteolytic 
products in the I/R samples in both young and aged, in 
the form of low molecular weight products in the post-
transfer gels. Thus, increased tyrosine nitration of 
GAPDH following I/R injury in both the young and the 
old muscle may lead to protein unfolding and increased 
susceptibility to aggregation or degradation [31, 32] 
which is one of several factors that may affect the 
protein pool level following I/R. We thus propose that 
tyrosine nitration, as an oxidative modification, may 
signal increased degradation by the 20S proteasome 
compared to the unmodified enzyme [30] or the 
chaperone-mediated autophagy pathways [29, 30, 33]. 
Specifically, in vitro tyrosine nitration increases the rate 
of enzyme degradation which is a potential mechanism 
for the decrease in GAPDH pool levels. The fact that 
GAPDH nitration remains elevated for a longer period 
of time in the old compared to young muscle, i.e., up to 
7 days supports our hypothesis that (a) oxidative stress 
and oxidative protein modification in aging and I/R are 
cumulative, and that (b) I/R injury, therefore, has a 
proportionately greater impact upon the old muscle, 
where antioxidant defenses are already taxed by 
chronically elevated ROS. As increased levels of 
nitration correlate with decreases in GAPDH pool levels 
for both age groups, it further suggests that oxidative 
modification may be driving proteolytic degradation of 
GAPDH following I/R injury.  
 
The decrease in GAPDH mRNA levels during 
reperfusion does not account for the deficit in GAPDH 
protein levels. Furthermore, the increase in rRNA may 
be a compensatory response to the decreased protein 
levels. The question that remains, however, is why are 
GAPDH protein levels so severely decreased in the 
presence of both mRNA and rRNA transcripts?  Our 
results thus suggest an alternative mechanism that 
Figure 9. Tyrosine nitration of GAPDH in plantaris/FHL
lysate from old mice. (A) Tyrosine nitration was assessed by
Western  blot  of  one  dimensional  gel  electrophoresis.  (B)
Densitometric  analysis  shows  nitration  was  significantly
increased for GAPDH at 1, 3, and 5 days of reperfusion. C =
contralateral  control  Is  =  I/R;  Group  I  =  1  day  reperfusion;
Group II = 3 days reperfusion; Group III = 5 days reperfusion,
and Group IV = 7 days reperfusion. * = p < 0.05. 
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lational processes. This possibility is supported by reports  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
that IGF-1 mRNA is upregulated following I/R, sug-
gesting that protein translation should be increased [2, 5]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Identification of  3-Nitrotyrosine Modified Proteins by Mass Spectrometry  
   
Young - 5 Days Reperfusion 
 
# 
Protein Name                     
(Mus Musculus) 
Protein 
MW 
Peptide 
Count 
Protein 
Score 
Protein    
PI 
Expectation 
Score 
1 
Aconitate hydratase, mitochondrial 
precursor  85,410.0 13 70  8.08  1.26E-03 
2  Actin, alpha cardiac muscle 1  41,991.9  10  450  5.23  1.26E-41 
3  Actin, alpha skeletal muscle  42,023.9  12  482  5.23  7.92E-45 
4  Actin, cytoplasmic 2  41,765.8  7  220  5.31  1.26E-18 
5  Actin, gamma-enteric smooth muscle  41,849.8  8  304  5.31  5.00E-27 
6 Annexin  A11  54,076.8  11  146  7.53  3.15E-11 
7 
ATP synthase subunit alpha, 
mitochondrial precursor  59,715.6  17  290  9.22  1.26E-25 
8 Carbonic  anhydrase  29,347.6  5  57  6.89  2.51E-02 
9  Carbonic anhydrase 3  29,347.6  8  183  6.89  6.29E-15 
10  Creatine kinase M-type  43,017.8  16  562  6.58  7.92E-53 
11  Desmin  53,456.0 12 67  5.21  2.51E-03 
12 
Dihydrolipoyl dehydrogenase, 
mitochondrial precursor  54,238.2  10  269  7.99  1.58E-23 
13  ETS-related transcription factor Elf-3  44,245.6  10  59  5.75  1.58E-02 
14  Fructose-bisphosphate aldolase A  39,331.3  10  108  8.31  1.99E-07 
15 
Glutamate dehydrogenase 1, 
mitocondrial precursor  61,298.2  8  75  8.05  3.97E-04 
16 
Glyceraldehyde-3-phosphate 
dehydrogenase 35,787.2  9  180  8.44  1.26E-14 
17 
Glycerol-3-phosphate dehydrogenase 
[NAD+], cytoplasmic  37,548.4  13  311  6.75  9.98E-28 
18  Heat shock protein beta-1  22,999.7  8  254  6.12  5.00E-22 
19  Malate dehydrogenase, cytoplasmic  36,488.1  7  188  6.16  1.99E-15 
20 
NADH dehydrogenase [ubiquinone] 
flavoprotein 2, mitochondrial 
precursor  27,267.9 4  54 7  5.00E-02 
21  Nebulin-related-anchoring  protein  195,651.6 23 59  9.35  1.58E-02 
22 Peroxiredoxin-6    24,855.0  5  149  5.71  1.58E-11 
23  Pyruvate kinase isozymes M1/M2  57,808.0  13  128  7.18  1.99E-09 
24  Rho GDP-dissociation inhibitor 1  23,392.8  11  270  5.12  1.26E-23 
25  Serum albumin precursor  68,647.7  5  207  5.75  2.51E-17 
26 Triosephosphate  isomerase  26,695.8  6  199  6.9  1.58E-16 
27 
UTP-glucose-1-phosphate 
uridylyltransferase  56,943.7 11 67  7.18  2.51E-03 
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Old - 5 Days Reperfusion 
 
# 
Protein Name                     
(Mus Musculus) 
Protein 
MW 
Peptide 
Count 
Protein 
Score 
Protein    
PI 
Expectation 
Score 
1  Actin, alpha cardiac muscle 1  41,991.9  4  98  5.23  1.99E-06 
2  Actin, alpha skeletal muscle  42,023.9  4  97  5.23  2.51E-06 
3  Actin, cytoplasmic 1  41,709.7  8  134  5.29  5.00E-10 
4  Actin, cytoplasmic 2  41,765.8  2  57  5.31  2.51E-02 
5  Actin, gamma-enteric smooth muscle  41,849.8  3  63  5.31  6.29E-04 
6 
Ankyrin repeat domain-containing 
protein 49  27,094.5  7  54  5.04  5.00E-02 
7 Annexin  A11  54,076.8  10  299  7.53  1.58E-26 
8 Apolipoprotein  A-1  precursor  30,568.7  17  622  5.64  7.92E-59 
9 
ATP synthase subunit alpha, 
mitochondrial precursor  59,715.6  16  383  9.22  6.29E-35 
10  Creatine kinase M-type  43,017.8  13  456  6.58  3.15E-42 
11  Fibrinogen beta chain precursor  54,717.7  8  90  6.68  1.26E-05 
12  Fructose-bisphosphate aldolase A  39,331.3  5  68  8.31  1.99E-03 
13 
Glyceraldehyde-3-phosphate 
dehydrogenase 35,787.2  5  150  8.44  1.26E-11 
14 
Ig gamma-2B chain C region 
membrane-bound form  44,231.2  3  174  6.1  3.00E-14 
15 
Ig gamma-2B chain C region secreted 
form 36,635.3  3  175  7.19  3.97E-14 
16  Ig kappa chain C region  11,770.5  2  68  5.23  1.99E-03 
17 Lamin-A/C  74,192.7  7  72  6.54  7.92E-04 
18  L-lactate dehydrogenase A chain  36,475.2  7  117  7.62  2.51E-08 
19 Myosin-1  223,203.0  8  161  5.6  9.98E-13 
20 Myosin-3  223,652.4  8  121  5.62  9.98E-09 
21 Myosin-4  222,719.9  9  264  5.58  5.00E-23 
22 Myosin-6  223,426.5  24  441  5.57  9.98E-41 
23 Myosin-7  222,740.5  28  537  5.59  2.51E-50 
24 Myosin-8  222,569.5  10  231  5.65  9.98E-20 
25  Nucleoside diphosphate kinase B  17,351.9  4  60  6.97  1.26E-02 
26  Peptidyl-prolyl cis-trans isomerase A  17,959.8  2  55  7.74  3.97E-02 
27 Phosphoglycerate  mutase  1  28,813.9  8  175  6.67  3.97E-14 
28 Phosphoglycerate  mutase  2  28,808.8  4  103  8.65  6.29E-07 
29  Putative RNA-binding protein 3  16,594.7  8  258  6.84  1.99E-22 
30 Serotransferrin  precursor  76,673.7  13  294  6.94  5.00E-26 
31  Serum albumin precursor  68,647.7  5  124  5.75  5.00E-09 
32  Strumpellin  134,024.8 12 57  6.72  2.51E-02 
28 Superoxide  dismutase  [Cu-Zn]  15,932.8  9  406  6.02  3.15E-37 
29 Transthyretin  precursor  15,766.0  9  446  5.77  3.15E-41 
30 Triosephosphate  isomerase  26,695.8  6  246  6.9  3.15E-21 
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Histological analyses (Hammers et al., personal 
communication) have shown significant levels of 
inflammatory cell infiltration at 5 days in both age 
groups. These inflammatory cells may contribute to the 
increase in total RNA seen in the I/R samples. Further 
studies should fully elucidate the contribution made by 
immune cells in the current results. 
 
The increase in rRNA following ischemia and 5 days 
reperfusion may provide increased capacity for protein 
synthesis. This is in contrast, however, to what has been 
reported in rats, where no difference was seen in the 
level of 18S rRNA in gastrocnemius at 7 days [2]. 
However, it should be noted that in addition to the 
differences in muscle choice, species, and time point, 
different experimental procedures may explain the 
discrepancy between these results. In the study by 
Hammers and Farrar [2], total RNA content was 
normalized prior to reverse transcription in accordance 
with accepted procedure. In our experiments, total RNA 
quality was assayed prior to balancing. After detecting 
consistently disparate amounts of total RNA between 
I/R and control we reasoned that the differences were 
not due to the slight variation in starting muscle weight 
or to random variation in the isolation procedure. We 
decided, therefore, that balancing the total RNA would 
eliminate true differences in rRNA abundance and 
obscure variation in mRNA abundance. As rRNA 
constitutes the greatest part of total RNA, one could 
potentially create a paradoxical and artifactual decrease 
in a specific mRNA if the level of that mRNA was 
increased to a lesser extent than the rRNA. We therefore 
continued to examine equal percentages of the total 
RNA isolated.  
 
Our findings that the rRNA is increased agree with the 
report that local insulin-like growth factor-1 (IGF-1) 
mRNA is increased in rat gastrocnemius following 2 
hours of ischemia and 7 days of reperfusion [2]. IGF-1 
has been reported to increase the transcriptional activity 
of RNA polymerase I in HEK293 cells to allow 
increased capacity for protein synthesis [34]. Increases 
in local IGF-1 have been reported following muscle 
injury in several different models [35, 36] including I/R  
hypoxia/reoxygenation [35]. The mechanism for this 
stimulation of ribosomal transcription is primarily via  
 
 
 
 
 
 
 
 
 
activation of the PI3K/Akt/mTOR pathway, although 
the Ras-MAPK pathway also contributes in HEK293 
cells [34]. 
 
Another possible mechanism for the decrease in GAPDH 
pool level following I/R is a deficient or dysfunctional 
translation. Thus, the severe decrease in the GAPDH pool 
levels of the young in the presence of GAPDH transcript 
suggests that dysfunction of translation may also be 
involved in the young following I/R [36, 37]. Our results 
argue that an examination of translation would be an 
important step in understanding the observed phenomena. 
It would also be important to examine the changes in 
GAPDH transcript at earlier time points, particularly in 
the young to determine when the level of GAPDH 
transcript is altered, whether this contributes to decrease 
in the protein level or whether translation may be 
impaired. There is a precedent for translational arrest 
following I/R injury from studies examining cerebral [38, 
39] and kidney I/R injury [40], although to our 
knowledge this has not been extended to skeletal muscle. 
In summary, the effects of I/R on GAPDH mRNA and 
rRNA do not adequately explain the decrease in GAPDH 
protein levels, suggesting alterations in protein 
homeostasis during recovery from I/R injury.  
 
Our studies raise the question of whether tyrosine 
nitration of GAPDH in I/R injury affects its enzymatic 
activity. It is unlikely that tyrosine nitration results in 
the initial loss of GAPDH activity based on the report 
that the loss of glycogen phosphorylase due to cysteine 
modification occurs prior to the detection of nitration 
[30, 41]. This is consistent with studies showing that: 
(a) mutation of cysteines in the GAPDH active site 
abolishes GAPDH glycolytic activity [27]; (b) oxidative 
modification by numerous agents results in loss of 
activity following modification of these active site 
cysteines, suggesting that cysteine oxidation following 
I/R injury in young and aged muscle may be an 
important physiological factor [42-45].  
 
Our studies raise the question as to what extent our 
findings might be generalized to muscle fibers with a 
more oxidative phenotype. Metabolic phenotype 
strongly correlates with sensitivity to oxidative stress 
[11, 12, 46, 47]. As skeletal muscle with an oxidative 
 
31  Tropomyosin alpha-1 chain  32,660.7  26  687  4.69  2.51E-65 
32  Tropomyosin alpha-3 chain  32,842.8  13  206  4.68  3.15E-17 
33  Tropomyosin alpha-4 chain  28,450.4  6  68  4.65  1.99E-03 
34  Tropomyosin beta chain  32,816.6  18  275  4.66  3.97E-24 
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stress, a comparison of GAPDH levels within 
predominately oxidative and predominately glycolytic 
muscles following I/R would provide a means of testing 
the hypothesis that oxidative stress and protein 
modification plays a major role in the observed decrease 
in GAPDH pool levels.  
 
Another potential consequence of decreased GAPDH 
expression is that loss of GAPDH could sensitize the 
surviving muscle to further insults such as ROS/RNS 
from a prolonged inflammatory response seen in old 
rats following I/R injury [2]. Furthermore, the loss or 
gain of sensitivity is a function of the level of GAPDH 
expression. This is consistent with the observation that 
over-expression of GAPDH can prevent caspase-
independent cell death in response to treatment with 
etoposide, staurosporine, or actinomycin D [27]; that 
chronic myelogenous leukemia (CML) cells resistance 
to imatinib therapy spontaneously upregulated GAPDH 
expression and that these resistant cells could be 
sensitized by siRNA knockdown of GAPDH expression 
[48].  
 
The central observation of this study is that GAPDH 
protein levels are decreased in both old and young 
muscle following I/R injury. Our data suggest a model 
of protein homeostasis following I/R injury in which 
increased oxidative modification and subsequent 
degradation of proteins leads to decreases in protein 
pool levels. Cessation of oxidative stress would, 
therefore, allow transcription and translation to return 
protein pools to normal. This is consistent with our 
observation that the declining levels of oxidative 
modification in the young correlate with the 
normalization of GAPDH pool levels whereas for the 
old animals normalization of GAPDH pool levels is 
significantly delayed, i.e., were not reached by 7 days in 
spite of evidence for increased GAPDH transcription. 
Thus, while the young have begun to recover the 
GAPDH pool level, either the prolonged oxidative 
stress and oxidative modification in the old mouse 
continues to drive protein degradation or that translation 
is impaired. Although our data support the hypothesis 
that degradation is responsible for the decreased 
GAPDH pool levels, we do not discount a significant 
role for decreased translation. 
 
METHODS 
 
Animals and tissues. Young (6-7 months) and old (24-
27 months) C57Bl/6 mice were used in these 
experiments. Prior to their use, the mice were 
acclimatized to their new surroundings for one week. 
Upon completion of the experiments, animals were 
euthanized using sodium pentobarbital. For one-
dimensional gel electrophoresis and Western blots, 3 
animals were used per time point, with the exception of 
the young at 1 day, which had 2 animals. Plantaris and 
flexor hallicus longus (FHL) muscles were collected for 
the one dimensional gels. Time points examined for 
young and old mice were 2 hours of ischemia followed 
by either 1, 3, 5, or 7 days of reperfusion. For the young 
mice, an additional time point with 2 hours of ischemia 
and no reperfusion was also examined. For two 
dimensional gel electrophoresis, a representative sample 
from the 5 day time point was selected from the young 
and the old samples. For RNA extraction and PCR 
analysis,  plantaris muscles from 6 young and 3 old 
animals were collected after 2 hours of ischemia 
followed by 5 days of reperfusion. All experimental 
procedures were approved by and conducted in 
accordance with guidelines set by the University of 
Texas at Austin IACUC.  
 
Ischemia/Reperfusion protocol. Tourniquet-induced I/R 
was performed as previously described [2]. Mice were 
anesthetized using 2% isofluorane prior to and for the 
duration of the tourniquet application. A heat lamp was 
used to maintain the animal’s body temperature at 32-35 
± 1
oC during the tourniquet procedure. After 2 hours, 
the tourniquet was removed, and the animal returned to 
its cage to recover. After the appropriate length of 
reperfusion, the muscles were taken, snap frozen in 
liquid nitrogen, and the samples were stored at -80
oC 
until analysis.  
 
Protein extraction. Flexor halicus longus and plantaris 
muscles were homogenized together in 2D lysis buffer 
(8 M urea, 4% CHAPS, 40 mM DTT, protease 
inhibitors) using the Ettan Sample grinding kit 
(Amersham BioSciences), according to manufacturer’s 
instructions. Briefly, the samples were homogenized in 
the sample grinding tube with abrasive resin by using 
the provided plastic pestles. The samples were 
centrifuged for 5 minutes at 10,000g to pellet the resin 
and debris. Supernatant was removed to a fresh tube. 
Additional 2D lysis buffer was added and the previous 
steps repeated to maximize yield. In some experiments 
supernatants were combined. 
 
Protein assays.  Bradford protein assays (BioRad) of 
muscle homogenates were performed in triplicate using 
bovine serum albumin as a protein standard. The 
Bradford assays were performed in triplicate after the 
samples were homogenized, and the average value used. 
The samples to an equal concentration. The samples 
were then diluted, aliquoted and frozen at -80
oC. until 
further use.  
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(30  μg) were mixed with 5X Laemli loading buffer 
(10% SDS, 500 mM DTT, 300 mM Tris, 50% glycerol, 
0.05% bromophenol blue, pH 6.8) and brought up to 25 
μL with 2D lysis buffer. Samples were separated on a 4-
20% tris-glycine gradient gel (Bio-Rad) at 135 volts for 
2 hours in SDS running buffer (25 mM Tris base, 0.1% 
SDS (w/v), 192 mM glycine). Immobilon PVDF 
membranes (Millipore) were prepared by wetting the 
membrane for 15 seconds in methanol, equilibrating the 
membrane in distilled water for 2 minutes, and then 
equilibrating the membrane in transfer buffer (25 mM 
Tris base, 10% methanol (v/v), 192 mM glycine) for 5 
minutes. Gel transfers were performed in a Hoeffer wire 
transfer tank at 50 volts for 2 hours at 4
oC.  
 
Two dimensional gel electrophoresis. Muscle samples 
(180 μg) isolated in 2D lysis buffer were mixed with 
Destreak reagent (GE –BioSciences) plus 0.75% IPG 3-
10 pH IPG buffer. Samples were made up to 200 μl 
with 2D lysis buffer. The sample was pipetted into an 
11 cm Ettan IPGphor strip holder (Amersham 
Biosciences) and overlaid with an 11 cm Immobiline 
Drystrip 4-7 pH gel strip (GE Biosciences) with the 
backing strip of the gel toward the top. Immobiline 
DryStrip cover fluid (Amersham BioSciences) was 
pipetted over the strip and sample to prevent 
evaporation, the cover placed on the holder, and the 
assembly rehydrated on an Ettan IPGphor isoelectric 
focusing system (Amersham Biosciences). Conditions 
used were as follows: 12 hours in-gel rehydration at 
20
oC with a constant current of 50 mA/strip followed by 
3 focusing steps – 500V for 50 Vh, 1000V for 1000Vh 
and 8000V for 16000Vh.  
 
Strips were equilibrated for 15 minutes in SDS 
equilibration buffer (6 M urea, 29.3% glycerol (v/v), 
2% SDS (w/v), 0.002% bromophenol blue (w/v), and 75 
mM Tris-HCl, pH 8.8. Prior to equilibration, DTT (1% 
w/v) was added to the SDS equilibration buffer. The gel 
strip was then placed in the sample lane of a 10-20% 
Tris-HCl IPG +1 well, 1 mm Criterion gel (BioRad) and 
sealed with agarose sealing solution (25 mM tris, 192 
mM glycine, 0.1% SDS (w/v), 0.5% agarose, and 
0.002% (w/v) bromophenol blue. After the agarose 
solidified the gels were placed in a Criterion running 
tank (BioRad), filled with running buffer (25 mM Tris 
base, 0.1% SDS (w/v), and 192 mM glycine). The 
sample was separated at 135 volts for approximately 2 
hours. The gel was transferred using a Criterion blotter 
system (BioRad) with conditions as described for 
transfer of 1D electrophoresis gels. 
 
Western blotting.  Membranes were blocked for one 
hour with 5% non-fat dried milk TBST (50.0 mM tris, 
200 mM NaCl, 0.05% Tween-20, pH 7.4) and probed 
overnight with anti-nitrotyrosine antibody 1:2000 5% 
milk, TBS-T. Membranes were washed 3X for 5 
minutes in TBS-T and probed with anti-mouse 
secondary antibody at RT for 1 hour. Prior to blotting 
membranes were washed 2X 5 minutes and 1X 15 
minutes in TBS-T. The membrane was then incubated 
with Immobilon blot substrate (Millipore) for 5 minutes 
and exposed to film (Biomax MR, Kodak).   Bands 
were assessed by densitometry (FluorChem 8900, 
AlphaInnotech). Membranes were stripped (Restore 
Western Blot Stripping Buffer, Pierce), reprobed with 
anti-mouse antibody to insure original primary anti-
nitrotyrosine removal and then probed with GAPDH 
antibody (clone CA6, Santa Cruz) 1:5000 in 5% milk, 
TBST for 1 hour. 
 
Protein normalization.  Total protein per lane was 
assessed by densitometry (FluorChem 8900, 
AlphaInnotech) with automatic background subtraction 
and a value of 100 was assigned to the lane with the 
highest density. The remaining lanes were expressed as 
a decimal fraction of the 100 lane. The reciprocal of the 
decimal was multiplied by the values generated from 
the Western data. For nitration of the 37 kD band, a 
ratio computed from the GAPDH western blot was used 
to normalize the amount of GAPDH present rather than 
total protein. A correction factor was also used between 
gels of the same age group by rerunning samples in 
separate gels and taking a ratio of the 37 kD bands in 
the first and second gels. The average of the ratios was 
used as the correction factor. For nitrotyrosine blots the 
ratio was based on total nitration of repeated samples. 
 
Sample preparation for mass spectrometry. Preparation 
of samples for mass spectrometry were performed by 
the Mass Spectrometry Core Facility at University of 
Texas Medical Branch, Galveston. Gel samples were 
cut into 1 mm size pieces or smaller and placed into 
separate 0.5 mL polypropylene tubes. Ammonium 
bicarbonate buffer (50 mM; 100 μl) was added to each 
tube and the samples were then incubated at 37
oC for 30 
minutes. After incubation the buffer was removed and 
100 μl of water was added to each tube. The samples 
were then incubated again at 37
oC for 30 minutes. After 
incubation the water was removed and 100 μl of 
acetonitrile was added to each tube to dehydrate the gel 
pieces. The samples were vortexed and after 5 minutes 
the acetonitrile was removed. Acetonitrile (100 μl) was 
again added to each of the sample tubes, vortexed and 
removed after 5 minutes. The samples were then placed 
in a speedvac for 45 minutes to remove excess solvent. 
Lyophilized trypsin (20 μg; Promega Corp.) was 
dissolved by adding 2 mL of 25 mM ammonium 
bicarbonate (pH 8.0). The trypsin solution was then 
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amount (~10 μL), i.e., just enough to cover the dried 
gel. The samples were then incubated at 37
oC for 6 hrs. 
After digestion the samples were removed from the 37
o 
C oven and 1 μL of sample solution was spotted directly 
onto a MALDI target plate and allowed to dry. Alpha-
cyano-4-hydroxycinnamic acid (1 μL; Aldrich 
Chemical Co.) matrix solution (50:50 acetonitrile/water 
at 5 mg/mL) was then applied on the sample spot and 
allowed to dry. The dried MALDI spot was further 
dried with compressed air (Decon Laboratories, Inc.) 
before inserting into the mass spectrometer.  
 
Mass spectrometry.  Matrix-Assisted Laser Desorption 
Ionization Time-of-Flight Mass Spectrometry (MALDI 
TOF-MS) was used to analyze the samples and 
determine protein identity. Data were acquired with an 
Applied Biosystems 4800 MALDI TOF/TOF 
Proteomics Analyzer. Applied Biosystems software 
package included 4000 Series Explorer (v. 3.6 RC1) 
with Oracle Database Schema Version (v. 3.19.0) and 
Data Version (3.80.0). The software was used to acquire 
both MS and MS/MS spectral data. The instrument was 
operated in positive ion reflectron mode with a mass 
range of 850 – 3000 Da, and the focus mass was set at 
1700 Da. For MS data, 1000-2000 laser shots were 
acquired and averaged from each sample spot. 
Automatic external calibration was performed using a 
peptide mixture with reference masses 904.468, 
1296.685, 1570.677, and 2465.199. 
 
Following MALDI-MS analysis, MALDI-MS/MS was 
performed on several (5-10) abundant ions from each 
sample spot. A 1kV positive ion MS/MS method was 
used to acquire data under post-source decay (PSD) 
conditions. The instrument precursor selection window 
was ±3 Da. For MS/MS data, 2000 laser shots were 
acquired and averaged from each sample spot. 
Automatic external calibration was performed using 
reference fragment masses 175.120, 480.257, 684.347, 
1056.475, and 1441.635 (from precursor mass 
1570.700). 
 
Applied Biosystems GPS Explorer
TM (v. 3.6) software 
was used in conjunction with MASCOT to search the 
respective protein database using both MS and MS/MS 
spectral data for protein identification. Protein match 
probabilities were determined using expectation values 
and/or MASCOT protein scores. MS peak filtering 
included the following parameters: mass range 800 Da 
to 4000 Da, minimum S/N filter = 10, mass exclusion 
list tolerance = 0.5 Da, and mass exclusion list (for 
some trypsin and keratin-containing compounds) 
included masses 842.51, 870.45, 1045.56, 1179.60, 
1277.71, 1475.79, and 2211.1. For MS/MS peak 
filtering, the minimum S/N filter = 10. 
 
For protein identification, the murine taxonomy was 
searched in the SwissProtein database. Other parameters 
included the following: selecting the enzyme as trypsin; 
maximum missed cleavages = 1; fixed modifications 
included carbamidomethyl (C) for 2-D gel analyses 
only; variable modifications included oxidation (M); 
precursor tolerance was set at 0.2 Da; MS/MS fragment 
tolerance was set at 0.3 Da; mass = monoisotopic; and 
peptide charges were only considered as +1. The 
significance of a protein match based on both the 
peptide mass fingerprint (PMF) in the first MS and the 
MS/MS data from several precursor ions, is based on 
expectation values; each protein match is accompanied 
by an expectation value. The expectation value is the 
number of matches with equal or better scores that are 
expected to occur by chance alone. The default 
significance threshold is p<0.05, so an expectation 
value of 0.05 is considered to be on this threshold. We 
used a more stringent threshold of 10
-3 for protein 
identification (a lower expectation value represents a 
more significant score). 
 
RNA extraction.  Total RNA extraction was 
accomplished using the RNAqueous-4PCR kit (Applied 
Biosystems, U.S.) according to manufacturer’s 
instructions. Plantaris muscle was collected from young 
(n=6) and old (n=3) mice subjected to 2 hours of 
ischemia and 5 days of reperfusion. The muscle samples 
were snap-frozen in liquid nitrogen and stored at -80
o C 
until use. The plantaris was cut in half on dry ice. One 
half of the muscle was transferred to a microfuge tube 
and homogenized by hand in the lysis/binding solution 
supplied with the kit using a plastic pestle. An equal 
volume of 64% ethanol was added to the solution and 
mixed. This mixture was pipetted into a tube containing 
a filter cartridge supplied with the kit. The cartridge and 
solution were centrifuged at 15,000g for 1 minute. 
Wash solution #1 was added to the retentate, and the 
tube was centrifuged as in the previous step. The 
previous wash and centrifugation was repeated twice 
using wash solution #2/3. The filter cartridge was 
placed into a new tube, and elution buffer pre-warmed 
to 70-80
o  C was added. The cartridge and tube were 
centrifuged at 15,000g for 1 minute. Another volume of 
heated elution buffer was added, and the cartridge was 
centrifuged again. Finally, the cartridge was removed 
and the total filtrate was centrifuged again. The 
supernatant was removed to a fresh tube, leaving any 
glass fibers from the cartridge in the pellet. Residual 
amounts of DNA were removed by treating the samples 
with DNase 1 provided in the RNAqueous kit. The 
samples were incubated at 37
oC for 20 minutes, and 
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were then gently vortexed, incubated with the 
inactivation reagent for 2 minutes and then centrifuged 
at 10,000g for 1 minute. The supernatant was then 
transferred to fresh tubes.  
 
To ascertain the quality of the extracted mRNA, the 
rRNA 6000 Nano Assay kit (Agilent Technologies, 
Germany) was used according to manufacturer’s 
instructions, in conjunction with the Agilent 2100 
bioanalyzer. This chip-based capillary gel 
electrophoresis unit utilizes a proprietary dye-based 
reagent that binds to nucleic acids for detection and 
quantitation of rRNA.  
 
cDNA synthesis.  Synthesis of cDNA was done using 
the SuperScript First-Strand Synthesis System for RT-
PCR (Invitrogen) according to manufacturer’s 
instructions. For each sample, an equal volume (8 μl) of 
DNAse-treated total RNA, 1 μl of 10 mM dNTP mix, 
and 1 μl of 0.5 μg/μl oligo(dT)12-18 was added to one 
well of a PCR reaction plate. A 2X reaction mixture 
was prepared which contained the following: 2 μl of 
10X reaction buffer, 4 μl of 25 mM MgCl2, 2 μl of 
0.1M DTT, and 1 μl RNaseOUT (provided in the kit). 
The RNA/primer mix was incubated at 65
oC for 5 
minutes using an Applied Biosystems GeneAmp 9700. 
The mixture was then placed on ice for 1 minute. Nine 
μl of the 2X reaction mixture was added to each 
reaction and mixed by pipetting. The reaction was 
incubated at 42
oC for 2 minutes in the Applied 
Biosystems GeneAmp 9700 prior to the addition of 1μl 
of SuperScript II reverse transcriptase to each reaction 
(with the exception that no reverse transcriptase was 
added to the negative control). The reaction plate was 
incubated at 42
oC for 50 minutes in the GeneAmp 9700. 
Subsequently, the temperature was increased to 70
oC 
for 15 minutes to terminate the reaction. The reaction 
plate was chilled on ice for 5 minutes. RNase H (1μl) 
was added to each well and the plate was incubated at 
37
 oC for 20 minutes.  
 
PCR.  PCR was performed using a Taq polymerase-
based fluorogenic assay and primers specific for 
GAPDH mRNA (Primetime qPCR, Integrated DNA 
Technologies). Primer sequences used were: 5’-
AATCTCCACTTTGCCACTG-3’ and 5’CCTCGTCCC 
GTAGA CAAAA-3’. Reactions were performed using 
the iCycler (Biorad) as follows: One period of 1.5 
minutes at 95
oC, followed by 50 cycles of 0.5 minutes 
at 95
oC, 0.5 minutes at 55
oC, and 0.5 minutes at 70
oC. 
 
Statistical analysis. The developed Western blot films 
were photographed using the FluorChem 8900 system 
(AlphaInnotech). Using the FluorChem 8900 spot 
densitometry analysis software, a rectangular area was 
selected which encompassed the region of interest. 
Selections for each lane were of equal area. The 
imaging software’s automatic background subtraction 
was used for examining the density of immunostaining 
for each band. After normalization, statistical analysis 
was performed as previously described [49, 50]. 
Welch’s modified version of the paired Student’s t-test 
was used to compare means between control and 
ischemic muscle of each time point, or between the 
difference in average response between young and old 
(within each time point). Welch’s modified version of 
the student t-test does not require that the sample 
variances be equal. Graphs represent the average of 
individual values (for example, the average GAPDH 
immunoreactivity of young controls versus the average 
of young I/R samples, at one day reperfusion). Error 
bars represent the standard deviation. 
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